Posts Tagged ‘sibutramine’

Too Quick to Kill Sibutramine?

May 23, 2015 — Was the reaction to kill sibutramine after a cardiovascular safety study in 2010 a mistake? A new study in the International Journal of Obesity raises that question with new data. Joseph Hayes and colleagues found found little risk of cardiovascular events in a cohort of more than 23,927 people receiving sibutramine, except in those people with […]

FDA Advisory Committee

September 15, 2010 — Adelphi, MD – FDA Advisory Committee on Endocrinologic and Metabolic Drugs advisory committee meeting to review the use of sibutramine in the treatment of obesity.  Theodore Kyle, RPh and chair of the The Obesity Society (TOS) Advocacy Task Force, presented a statement on behalf of TOS urging the panel to balance the need for effective treatments with […]